X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs GSK PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD GSK PHARMA ALEMBIC LTD/
GSK PHARMA
 
P/E (TTM) x 127.6 65.0 196.4% View Chart
P/BV x 4.7 10.4 45.4% View Chart
Dividend Yield % 0.2 1.2 19.5%  

Financials

 ALEMBIC LTD   GSK PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
GSK PHARMA
Mar-17
ALEMBIC LTD/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs533,838 1.4%   
Low Rs292,637 1.1%   
Sales per share (Unadj.) Rs4.7354.2 1.3%  
Earnings per share (Unadj.) Rs8.839.8 22.1%  
Cash flow per share (Unadj.) Rs9.042.9 21.0%  
Dividends per share (Unadj.) Rs0.1530.00 0.5%  
Dividend yield (eoy) %0.40.9 39.4%  
Book value per share (Unadj.) Rs27.7236.9 11.7%  
Shares outstanding (eoy) m267.0384.70 315.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.79.1 95.2%   
Avg P/E ratio x4.781.4 5.7%  
P/CF ratio (eoy) x4.675.5 6.0%  
Price / Book Value ratio x1.513.7 10.8%  
Dividend payout %1.775.4 2.3%   
Avg Mkt Cap Rs m10,962274,216 4.0%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m2384,830 4.9%   
Avg. sales/employee Rs ThNM6,387.0-  
Avg. wages/employee Rs ThNM1,028.3-  
Avg. net profit/employee Rs ThNM717.1-  
INCOME DATA
Net Sales Rs m1,26030,000 4.2%  
Other income Rs m264728 36.2%   
Total revenues Rs m1,52430,728 5.0%   
Gross profit Rs m834,190 2.0%  
Depreciation Rs m61263 23.3%   
Interest Rs m00-   
Profit before tax Rs m2854,655 6.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32457 -7.0%   
Tax Rs m61,744 0.3%   
Profit after tax Rs m2,3433,368 69.6%  
Gross profit margin %6.614.0 47.0%  
Effective tax rate %2.137.5 5.7%   
Net profit margin %185.911.2 1,655.8%  
BALANCE SHEET DATA
Current assets Rs m1,68916,742 10.1%   
Current liabilities Rs m4867,202 6.8%   
Net working cap to sales %95.431.8 300.1%  
Current ratio x3.52.3 149.4%  
Inventory Days Days21752 418.7%  
Debtors Days Days8121 389.9%  
Net fixed assets Rs m1,6248,635 18.8%   
Share capital Rs m534847 63.1%   
"Free" reserves Rs m5,96019,222 31.0%   
Net worth Rs m7,40420,069 36.9%   
Long term debt Rs m10410 1,043.0%   
Total assets Rs m8,01030,038 26.7%  
Interest coverage x950.7NM-  
Debt to equity ratio x00 2,827.1%  
Sales to assets ratio x0.21.0 15.8%   
Return on assets %29.311.2 260.9%  
Return on equity %31.616.8 188.5%  
Return on capital %31.325.5 122.9%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Exports (fob) Rs m37NA-   
Imports (cif) Rs m364NA-   
Fx inflow Rs m37528 7.0%   
Fx outflow Rs m3657,193 5.1%   
Net fx Rs m-328-6,665 4.9%   
CASH FLOW
From Operations Rs m3462,360 14.6%  
From Investments Rs m-483,008 -1.6%  
From Financial Activity Rs m-301-5,108 5.9%  
Net Cashflow Rs m-3260 -1.2%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 0.2 10.2 2.0%  
FIIs % 9.7 23.8 40.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 15.4 169.5%  
Shareholders   54,701 102,036 53.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 19, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - NOVARTIS COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS